Lyso-6

Treatment option:

Medically reviewed

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lyso-6

Quick Facts

Property	Description
Active Ingredients	Lysozyme hydrochloride and Pyridoxine hydrochloride
Form	Sublingual tablet (Oromucosal)
Pharmacological Class	Local Antiseptic and Vitamin Supplement combination
Common Use	Relief of minor mouth and throat discomfort
Origin	Combination (Natural enzyme and synthetic vitamin)

What Type of Medicine is Lyso-6? (Definition and Classification)

Lyso-6 is a combination pharmaceutical preparation classified as a Local Antiseptic and Vitamin Supplement combination, primarily used to address mild, localized irritations in the throat and mouth. The medication is specifically formulated as a sublingual tablet, an oromucosal form designed to dissolve slowly, ensuring the local and sustained release of its active components onto the affected tissues. This dual-component approach is intended to provide targeted relief, distinguishing Lyso-6 from single-action treatments.

Composition: Lysozyme and Pyridoxine Hydrochloride

The active foundation of Lyso-6 rests on the enzyme Lysozyme hydrochloride and the vitamin Pyridoxine hydrochloride (Vitamin B6). Lysozyme is a natural enzyme source derived typically from hen's egg white, while Pyridoxine is the stable, synthetic vitamin compound. Lysozyme acts as a muramidase, an enzyme that specifically hydrolyzes the cell wall of certain bacteria, contributing to a local antiseptic effect. The addition of Pyridoxine hydrochloride is intended to support the health and maintenance of the protective lining of the mouth, aiding in the mucosal integrity support of the irritated tissues.

General Purpose: How Lyso-6 Supports Oral Health

Lyso-6 is intended to relieve symptoms of minor discomfort and support the maintenance of normal tissue structure related to irritations in the oral cavity. Its utility lies in providing a targeted defense support through Lysozyme, complemented by the supportive role of Pyridoxine. For example, the preparation is commonly used when an individual experiences a non-febrile, slight sore throat or a developing mouth ulcer. Pyridoxine serves a general supportive role in maintaining epithelial health, which is important in managing minor lesions. This two-part action makes the preparation useful for symptoms such as small mouth sores or slight, localized throat discomfort.

Regulatory References

NIH PubChem Substance Lysozyme

What side effects are possible with Lyso-6?

Possible Side Effects and Safety Information for Lyso-6

Lyso-6 is associated with a risk of infusion reactions and hypersensitivity reactions, including anaphylaxis, which are potentially life-threatening and require immediate medical intervention. For this reason, Lyso-6 must be administered in a healthcare setting equipped to manage such emergencies, and patients must be closely monitored during and after the infusion.

Key Adverse Reactions

Infusion Reactions are the most frequently reported adverse event, typically occurring within 24 hours of administration. Symptoms can vary but may include headache, rash, itching (pruritus), fever, flushing, and changes in blood pressure. Managing these reactions may involve temporarily slowing or stopping the infusion.

Commonly Reported Side Effects (5% incidence in clinical trials) observed across various body systems include:

Infections: Upper respiratory tract infection, nasopharyngitis, pharyngitis, urinary tract infection.
Musculoskeletal: Arthralgia (joint pain), back pain, extremity pain.
Other: Headache, fatigue, nausea, dizziness, vomiting, abdominal pain.

Safety Considerations and Restrictions

Regulatory documentation emphasizes the risk of Severe Hypersensitivity Reactions and Anaphylaxis. If anaphylaxis occurs, the Lyso-6 infusion must be immediately discontinued.

Safety data is available for use in pediatric patients (4 years old) and geriatric patients. Use during pregnancy and lactation is covered in regulatory labeling. The drug's safety profile requires administration to be supervised by a healthcare provider knowledgeable in the management of severe allergic reactions.

Overdose and Emergency Response

Overdose and when to seek help

The primary documented risk associated with excessive use of Lyso-6 is related to the Pyridoxine hydrochloride (Vitamin B6) component, rather than the Lysozyme hydrochloride. The official labeling indicates that a Lyso-6 overdose is generally defined by the consequences of high doses taken over a long period of time (several months or even years).

Documented Overdose Presentation

The main clinical manifestation of prolonged, high-dose exposure is peripheral neuropathy, which may include the following symptom cluster:

Tingling and numbness of the extremities of the limbs
Disturbance of balance
Tremors of the hands and feet
Difficulty in coordinating movements

These effects are generally considered reversible when the medication is stopped.

Required Emergency Action

Immediate medical help is required in the event of the appearance of these disorders (tingling, numbness, balance disturbance, or tremors). Patients should consult a doctor promptly so that appropriate treatment and monitoring can be initiated. Additionally, for therapeutic use, if the symptoms of the initial condition (sore throat, mouth sores) do not improve after five days or if fever appears, a medical consultation is necessary.

Therapeutic Uses of Lyso-6

Management of Minor Oral Lesions and Mucosal Discomfort

The Lysozyme and Pyridoxine combination is a local preparation relevant in contexts where additional symptomatic support is needed for limited discomforts in the oropharyngeal area. Its therapeutic scope is used in situations involving certain distressing symptoms that create noticeable physiological strain. This preparation is applied across specific oral conditions, including minor mouth ulcers (aphthae), small cuts or sores in the mouth, and mild soreness and localized irritation in the throat.

Management of Minor Oral Lesions and Mucosal Discomfort

This preparation is commonly used across conditions presenting with acute episodes characterized by small, localized lesions. This application helps address symptom clusters that may appear suddenly and interfere with daily comfort. The preparation provides supportive relief that may help ease the overall symptom burden, and assists with managing symptoms related to functional stress.

"It is relevant in contexts involving increased discomfort or tension during localized, non-severe irritative episodes."

Property	Description
Therapeutic Focus	Relief for Localized Oral Discomfort and Minor Pharyngeal Irritation

Supportive Relief for Mild Throat Irritation

The preparation is relevant for acute, non-systemic episodes involving mild soreness and localized irritation in the throat. It is applied in settings where short-term symptomatic assistance is needed for slight pharyngeal discomfort, particularly when symptoms are not accompanied by fever. This supportive action may offer symptomatic relief that assists with managing symptoms that interfere with daily comfort, and may help improve day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Lyso-6

The official regulatory profile for Lyso-6 (Lysozyme hydrochloride and Pyridoxine hydrochloride) defines eligibility based on a combination of known sensitivities and mandatory demographic restrictions.

Category	Official Regulatory Status
Populations for whom use is allowed	Adults and children aged 6 years and older are the intended user population.
Populations for whom use is contraindicated	Individuals with known hypersensitivity to Lysozyme or Pyridoxine, or known allergy to hen's egg. Children under 6 years of age.
Age-related eligibility rules	Use is strictly contraindicated in children under 6 years of age.

Classification	Official Regulatory Wording
Eligibility severity classification	Absolute Contraindication (Hypersensitivity, Egg Allergy, Age < 6 years); Not Recommended (Pregnancy, Lactation, Specific Metabolic Disorders).
Pregnancy and lactation eligibility status	Use is generally not recommended or should be avoided due to insufficient safety data.

Connection to the overall eligibility profile:

Regulatory documents establish non-eligibility through absolute contraindications targeting individuals with component or source allergies and a definitive pediatric age cutoff. Furthermore, Lyso-6 is not recommended for patients with specific hereditary metabolic disorders due to excipient suitability. Use during pregnancy and lactation is generally avoided or restricted due to a lack of established safety data in these physiological states.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Lyso-6 (Lysozyme hydrochloride and Pyridoxine hydrochloride), based on governmental regulatory sources.

Documented Pharmacokinetic and Pharmacodynamic Interactions

The primary interaction constraints stem from the Pyridoxine hydrochloride component ( Vitamin B6), which is known to interfere with the systemic exposure of certain medications. This is documented as a metabolic interaction that affects drug levels:

Interacting Substance	Official Interaction Pattern
Levodopa (as monotherapy)	Pyridoxine enhances the peripheral metabolism of Levodopa, reducing the effective central concentration and is subject to a formal restriction.
Anticonvulsants (e.g., Phenytoin, Phenobarbitone)	Pyridoxine has been reported to decrease the serum concentrations of these agents, which may affect their circulating exposure.
Anti-tuberculosis Agents (e.g., Isoniazid, Cycloserine)	These medicines may increase the body’s requirement for Pyridoxine, antagonizing its effect and potentially leading to a deficiency.

Local Additive Exposure and Substance Restrictions

Official regulatory information includes a constraint related to local administration. Lyso-6 must not be used simultaneously with other local preparations containing antiseptics or its active components. This restriction is intended to prevent exceeding maximum recommended local dose limits of the active ingredients.

Absence of Food and Substance Interactions

Regulatory documents for Lyso-6 explicitly confirm the absence of documented interactions with food, beverages, alcohol, or herbal products.

Mechanism of Action

Lyso-6, containing the enzyme lysozyme, functions as a glycoside hydrolase targeting the cell wall of bacteria, primarily those that are Gram-positive. The enzyme acts as an agonist by binding to and cleaving the beta-(1,4)-glycosidic bond between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues within the peptidoglycan layer. This hydrolytic interaction is a molecular pathway that directly compromises the structural integrity and rigidity of the bacterial cell wall. The resulting molecular consequence is the disintegration of the peptidoglycan mesh, which leads to a downstream cascade of events involving loss of cellular turgor and osmotic instability. At the system level, this targeted structural breakdown results in the modulation of bacterial populations within the relevant tissues. Lysozyme is also involved in intracellular pathways by influencing immune signaling. It can modulate the production of pro-inflammatory cytokines, specifically suppressing the release of mediators like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) by immune cells, which constitutes a systemic physiological modulation of inflammatory response elements.

Dosage and Administration Information

How to Use Lyso-6

Lyso-6, a combination preparation of Lysozyme hydrochloride and Pyridoxine hydrochloride, is administered through the oromucosal route using a sublingual tablet. The general principles of its use involve specific parameters concerning administration method, frequency, and duration.

Official Administration Guidelines

Feature	Detail
Route of Administration	Oromucosal, via sublingual application.
Dosage Strength	Each sublingual tablet contains Lysozyme 20 mg and Pyridoxine 10 mg.
Standard Dosing	The labeled range is 6 to 8 tablets per day for the approved population.
Administration Method	The tablet must be allowed to melt slowly under the tongue; it is not intended to be chewed or swallowed whole.

Usage Patterns and Constraints

Administration is reserved for adults and children over 6 years of age. To ensure the local effect is maintained, doses must be spaced out regularly throughout the day, with a mandatory minimum interval of one hour between doses. The total course of administration is constrained to a maximum duration of 5 days. If symptoms persist beyond this short-term limit, the use of the preparation is intended to be discontinued. Furthermore, it is established that the product should not be used concurrently with other medicines containing antiseptics or Pyridoxine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lyso-6

Evidence for Mild Sore Throat and Localized Pharyngeal Irritation

Research into Lyso-6, which contains Lysozyme and Pyridoxine, has investigated the combination in the context of symptoms of mild soreness and localized irritation in the throat using short-term Randomized Controlled Trials (RCTs) and comparative pilot studies. These studies primarily examined adult patients and monitored patient-reported outcomes, such as the intensity of throat pain and assessments of swallowing difficulty. Findings describe patterns observed over defined time intervals, typically ranging from three to seven days.

However, the evidence base includes many pilot or small-scale studies, which means the results apply only to the populations studied. Long-term outcomes and effects beyond the short follow-up durations are not well characterized in available data.

Evidence for Minor Oral Lesions and Mucosal Discomfort

The research base for examining this combination in the context of minor oral lesions and mucosal tissues includes observational studies, cohort substudies, and prospective research. These studies explored how Lyso-6 was associated with managing discomfort related to minor mouth ulcers (aphthae) and monitored pain intensity, such as pain experienced when eating or drinking.

Data show patterns related to how individuals managed episodic or acute changes in their oral tissues, with studies observing responses over time intervals extending up to two or three weeks. Direct evidence from large-scale, dedicated trials focusing specifically on common mouth ulcers with only the Lysozyme/Pyridoxine combination is scarce. The evidence base often relies on observational research conducted in specific patient contexts, meaning data for certain groups remain insufficient, and certainty remains low.

Research Gaps and Areas of Uncertainty

Several factors define areas of uncertainty in the research for Lyso-6. Evidence quality varies across studies, and many of the available trials used modest sample sizes. This affects the certainty with which findings can be interpreted. Additionally, the prevalence of observational settings for minor oral lesions, combined with limited follow-up durations across most primary studies, means the data available provide limited insight into long-term outcomes or the management of chronic conditions.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Lyso-6 (FAQ)

Q: How long does Lyso-6 stay in my system?

A: Lyso-6 contains two active components: Lysozyme and Pyridoxine. Official product information describes that the Pyridoxine component (Vitamin B6) is readily absorbed and metabolized, mainly in the liver, before its breakdown products are excreted through the urine. This information describes the general elimination pathway for the vitamin component, which is excreted from the body.

Q: Does Lyso-6 interact with supplements like vitamins or herbal remedies?

A: Official regulatory documents confirm that interactions with herbal products or alternative therapies are not documented for Lyso-6. However, because this medicine already contains Pyridoxine (Vitamin B6), it should not be combined with other medicines or supplements containing the same active components. This restriction is intended to prevent exceeding the officially defined maximum amounts of the active ingredients.

Q: Why does the label warn about sun exposure while using Lyso-6?

A: Official regulatory documents and the patient information leaflet for Lyso-6 do not contain any specific warnings or precautions concerning sun exposure or photosensitivity while using this preparation.

Q: Can Lyso-6 be used with over-the-counter painkillers?

A: Regulatory documents list specific classes of prescription medicines, such as Levodopa and certain anticonvulsants, that may interact with the Pyridoxine component. Official guidance also stipulates that the preparation should not be used simultaneously with other local preparations containing antiseptics. Official guidance suggests that questions regarding concurrent use with any other medicine, including over-the-counter drugs, be addressed to a healthcare professional.

Q: Do I need to change my diet while I am taking Lyso-6?

A: According to the official labeling, interactions between Lyso-6 and food or drink are stated as not applicable. This indicates that no specific dietary restrictions are required for the medicine.

Q: Is Lyso-6 a type of antibiotic?

A: Official labeling classifies Lyso-6 as a combination pharmaceutical preparation belonging to the pharmacological class of a Local Antiseptic. This classification means it is typically used to address mild, localized irritation in the throat and mouth, rather than being a systemic antibiotic.

Q: Are there different strengths of Lyso-6 available?

A: Official regulatory documents define the standard dosage strength as one sublingual tablet containing Lysozyme 20 mg and Pyridoxine 10 mg. The documentation does not specify other strengths for this medicine.

Q: What if I have an existing heart condition? Can I still use Lyso-6?

A: Heart conditions are not listed among the official contraindications for Lyso-6. Contraindications are defined as known hypersensitivity to the components, known allergy to hen's egg, and use in children under 6 years of age.

Q: Does Lyso-6 affect birth control pills?

A: Official regulatory documents for this combination preparation do not list hormonal contraceptives, such as birth control pills, as a documented interaction or contraindication.

Q: Is Lyso-6 suitable for people with kidney problems?

A: Official documents do not list kidney problems or renal impairment as a contraindication or specific precaution for this product.

Q: Does Lyso-6 change how other medicines work in the body?

A: Official documentation indicates that the Pyridoxine component of Lyso-6 is documented to interact with certain medications. For example, it is described as enhancing the peripheral metabolism of medicines, such as Levodopa, which may reduce the effective amount of Levodopa in the central nervous system.

Q: Why does the official document mention Lyso-6 can affect liver enzymes?

A: The official regulatory documents, including sections on adverse reactions and warnings, do not contain information or warnings indicating that Lyso-6 affects liver enzymes.

How should Lyso-6 be stored and disposed of?

Storage and Disposal Conditions for Lyso-6

Official regulatory labeling dictates strict conditions for storing and disposing of Lyso-6 sublingual tablets. The medicine must be stored at a temperature not exceeding 30 C and must be protected from moisture to maintain product stability. To adhere to these rules and ensure safety, the tablets must remain in their original package and be kept out of the reach and sight of children.

Disposal

The product must not be used after the expiry date stated on the carton. When disposing of unused or expired medicine, regulatory documents prohibit discarding Lyso-6 via wastewater or ordinary household waste. Instead, the user must ask a pharmacist for guidance on proper disposal, which ensures compliance with local environmental requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

France

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z